COYA: Total Utang marang Modal Coya

Logo perusahaan publik Coya Therapeutics, Inc. (COYA)

Coya Therapeutics, Inc. (COYA) develops innovative treatments for ALS and Alzheimer's disease by suppressing inflammatory processes in the body. This chart of share price dynamics illustrates the company's financial standing, where the individual debt-to-equity ratio stands at 0.00. The business possesses excellent global growth potential driven by patent-protected technologies, while operations remain limited to laboratory standards that preclude harmful industrial emissions.

COYA - Total Utang marang Modal Coya ing rentang 28.04.2023 - 01.11.2026

Rincian metrik lan analitis perusahaan Coya Therapeutics (COYA)

- rega lan prakiraan konsensus rega:
Bagan rega Coya Therapeutics Inc|COYA - Prakiraan gabungan firma investasi
- informasi kapitalisasi pasar:
Kapitalisasi pasar Coya Therapeutics|COYA - Total Nilai Perusahaan
- indikator kapitalisasi buku:
Nilai Akuntansi saben Saham Coya Therapeutics|COYA - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku coyatherapeutics.com|COYA - Nilai Agregat Aset
- indikator beban kredit lan likuiditas emiten:
Utang marang Ekuitas Coya Therapeutics, Inc.|COYA - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang modal Coya Therapeutics Inc|COYA - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Coya Therapeutics|COYA - Utang jangka dawa|Kewajiban jangka cendhak perusahaan Coya Therapeutics|Rasio cepet coyatherapeutics.com
- statistik bathi lan rasio pasar:
COYA - Bathi resik
Analisis komprehensif perusahaan:COYA, Coya Therapeutics, Inc.
Barang utama Coya Therapeutics

The market audit of Coya Therapeutics, Inc. (COYA) focuses on the company's ability to fund development amid geopolitical barriers hindering global clinical trials. By analyzing changes in the debt-to-equity ratio, investors assess the proportion of external liabilities within the asset structure, where an increase in this metric signals elevated financial risks and reduced business resilience to external shocks.

Pesaing Coya Therapeutics, Inc.

Utang marang Ekuitas Biogen|Rasio Utang marang Ekuitas NBIX (Neurocrine)|Total Utang marang Modal RGC|AXSM - Utang marang Modal|ACADIA Pharmaceuticals - Rasio Total Utang marang Ekuitas|Total Utang marang Modal xenon-pharma.com XENE|VKTX - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi SUPN (Supernus Pharmaceuticals, Inc.)|Catalyst Pharmaceuticals Inc (CPRX) - Utang marang Ekuitas|Utang marang Modal Denali Corp (DNLI)|HRMY (Harmony Biosciences) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas biohavenpharma.com (BHVN)|Utang marang Ekuitas Amylyx Pharmaceuticals, Inc. (AMLX)|TRVI - Utang marang Modal|Praxis Medicines - Rasio Total Utang marang Ekuitas|Anavex Life Sciences Corp (AVXL) - Utang marang Modal|CeriBell, Inc. - Total Utang marang Modal|PRTA - Total Utang marang Modal|ALEC (alector.com) - Rasio Total Utang marang Ekuitas|Annexon Biosciences - Rasio Kabeh Utang marang Dana Pribadi|Rasio Total Utang marang Ekuitas OMER|NGNE (Neurogene Therapeutics) - Utang Agregat marang Modal|Total Utang marang Modal ACIU|VYGR (voyagertherapeutics.com) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal NMRA (Neumora Therapeutics, Inc.)|Scilex Holding (SCLX) - Utang marang Modal|TVGN - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi ACOG (Alpha Cognition)|CGTX: Total Utang marang Modal|inhibikase.com (IKT) - Total Utang marang Modal|Utang marang Ekuitas Cassava Sciences|Assertio Therapeutics - Utang Agregat marang Ekuitas|Total Utang marang Modal VTGN|OVID - Utang marang Modal|Acumen Pharmaceuticals - Rasio Total Utang marang Ekuitas|Total Utang marang Modal cervomed.com CRVO|ATHE: Rasio Total Utang marang Ekuitas|Clene Inc. - Utang Agregat marang Modal|PEPG: Total Utang marang Modal|JUNS - Koefisien Total Utang marang Modal|RLMD (Relmada Therapeutics) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas annovisbio.com (ANVS)|Utang marang Ekuitas Grace Therapeutics, Inc. (GRCE)|Koefisien Total Utang marang Modal Firefly Neuroscience, Inc.|Klotho Neurosciences - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi NRSN|Reviva Pharmaceuticals - Total Utang marang Modal|Koefisien Total Utang marang Modal MetaVia Inc MTVA|NeurAxis (NRXS) - Utang marang Ekuitas|Rasio Utang marang Ekuitas HSDT|PASG (Passage Bio Inc.) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas Neuphoria (NEUP)|Rasio Total Utang marang Ekuitas NERV (Minerva Neurosciences)|Koefisien Total Utang marang Modal athira.com|Total Utang marang Modal ADXN (Addex Therapeutics Ltd)|ALZN - Rasio Total Utang marang Ekuitas|CYCN - Utang marang Ekuitas|Utang marang Modal Protagenic Therapeutics|KTTA (pasitheaclinics.com) - Rasio Total Utang marang Ekuitas|Utang marang Modal Cortigent (CRGT)|ATXI (Avenue Therapeutics, Inc.) - Total Utang marang Modal|Total Utang marang Modal Brainstorm Cell Therapeutics Inc.|Utang marang Ekuitas Cara Therapeutics, Inc (CARA)|Chromocell - Rasio Utang marang Ekuitas|Total Utang marang Modal ELYM (Eliem Therapeutics Inc.)|Intra-Cellular Therapies Inc. (ITCI) - Utang marang Modal|LBPH: Rasio Total Utang marang Ekuitas|MRNS - Total Utang marang Modal|NKGen (NKGN) - Utang marang Ekuitas|NeuroBo Pharma - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Sage Therapeutics, Inc.|Utang marang Modal synaptogen.com SNPX|Total Utang marang Modal TRVN|Rasio Total Utang marang Ekuitas vigilneuro.com VIGL|Utang marang Ekuitas Anew Medical WENA|Cerevel Corp (CERE) - Utang marang Modal